NZ182665A - Amine derivatives and pharmaceutical compositions - Google Patents

Amine derivatives and pharmaceutical compositions

Info

Publication number
NZ182665A
NZ182665A NZ182665A NZ18266576A NZ182665A NZ 182665 A NZ182665 A NZ 182665A NZ 182665 A NZ182665 A NZ 182665A NZ 18266576 A NZ18266576 A NZ 18266576A NZ 182665 A NZ182665 A NZ 182665A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
amine derivatives
amine
derivatives
pharmaceutical
Prior art date
Application number
NZ182665A
Other languages
English (en)
Inventor
G Lambelin
C Gillet
R Roneucci
J Roba
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of NZ182665A publication Critical patent/NZ182665A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NZ182665A 1975-11-18 1976-11-18 Amine derivatives and pharmaceutical compositions NZ182665A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7535217A FR2332010A1 (fr) 1975-11-18 1975-11-18 Amino-alcool heterocyclique, son sel et son procede de preparation

Publications (1)

Publication Number Publication Date
NZ182665A true NZ182665A (en) 1978-11-13

Family

ID=9162563

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ182665A NZ182665A (en) 1975-11-18 1976-11-18 Amine derivatives and pharmaceutical compositions

Country Status (21)

Country Link
JP (2) JPS5297952A (fi)
AT (1) AT355566B (fi)
AU (1) AU510315B2 (fi)
BE (1) BE848496A (fi)
CA (1) CA1094088A (fi)
CH (2) CH623321A5 (fi)
DE (1) DE2651572C2 (fi)
DK (1) DK151330C (fi)
ES (1) ES453389A1 (fi)
FI (1) FI763265A (fi)
FR (1) FR2332010A1 (fi)
GB (1) GB1565080A (fi)
GR (1) GR62012B (fi)
IE (1) IE44265B1 (fi)
IL (1) IL50932A (fi)
MX (1) MX4881E (fi)
NL (1) NL180936C (fi)
NZ (1) NZ182665A (fi)
PT (1) PT65853B (fi)
SE (1) SE434744B (fi)
ZA (1) ZA766907B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512817A1 (fr) * 1981-09-17 1983-03-18 Roussel Uclaf Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation
US4622399A (en) * 1983-06-30 1986-11-11 American Home Products Corporation Bicyclo-heterocyclic nitrogen substituted aminoethanol derivatives
US4562200A (en) * 1983-06-30 1985-12-31 American Home Products Corporation 5(Indolyl) and 5(2,3-dihydroindolyl) substituted aminoethanols and their use as anti-hypertensives
US4521606A (en) * 1983-06-30 1985-06-04 American Home Products Corp. 5-Indolyl substituted aminoethanols
EP0567090B1 (en) 1992-04-24 2000-07-26 Takeda Chemical Industries, Ltd. Benzoxazepine derivatives as cholinesterase inhibitors
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5674891A (en) * 1994-07-27 1997-10-07 The Procter & Gamble Company Dihydrobenzothiophene compounds useful as anti-inflammatory agents
US5684002A (en) * 1994-09-07 1997-11-04 The Procter & Gamble Company Dihydorbenzofuran and related compounds useful as anti-inflammatory agents
WO1997025311A1 (fr) 1996-01-10 1997-07-17 Asahi Kasei Kogyo Kabushiki Kaisha Nouveaux composes tricycliques et compositions medicamenteuses contenant ces composes
US5684031A (en) * 1996-02-01 1997-11-04 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5672620A (en) * 1996-02-01 1997-09-30 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
WO1998033793A1 (fr) * 1997-01-30 1998-08-06 Sanofi-Synthelabo DERIVES DE α-AZACYCLOMETHYL BENZOTHIOPHENE ET DE α-AZACYCLOMETHYL BENZOFURANE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
WO1999001431A1 (fr) * 1997-07-03 1999-01-14 Asahi Kasei Kogyo Kabushiki Kaisha Nouveaux composes tricycliques presentant des noyaux satures et compositions medicinales les contenant
DK1277736T3 (da) 2000-04-28 2007-10-01 Asahi Kasei Pharma Corp Hidtil ukendte bicykliske forbindelser
DK1447400T3 (da) 2001-10-25 2008-12-08 Asahi Kasei Pharma Corp Bicyklisk forbindelse
CN102171192A (zh) 2008-10-09 2011-08-31 旭化成制药株式会社 吲唑化合物
CA2737349A1 (en) 2008-10-09 2010-04-09 Asahi Kasei Pharma Corporation Indazole derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1013224A (en) * 1962-06-21 1965-12-15 Ici Ltd Heterocyclic aminoethanols
US3255249A (en) * 1963-04-26 1966-06-07 Ici Ltd 2-branched lower alkyl-amino-1-(indan-, hydrogenated indan- and hydrogenated naphth-2-yl) lower alkanols
CH442302A (de) * 1964-04-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Indolderivates
FR2138488A1 (en) * 1971-05-27 1973-01-05 Lipha 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity

Also Published As

Publication number Publication date
JPS57145843A (en) 1982-09-09
ES453389A1 (es) 1977-11-16
IL50932A0 (en) 1977-01-31
IE44265L (en) 1977-05-18
PT65853A (fr) 1976-12-01
ZA766907B (en) 1977-10-26
MX4881E (es) 1982-11-30
AU1977976A (en) 1978-05-25
GR62012B (en) 1979-02-15
SE434744B (sv) 1984-08-13
AT355566B (de) 1980-03-10
FI763265A (fi) 1977-05-19
DE2651572A1 (de) 1977-06-08
JPS63435B2 (fi) 1988-01-07
JPS5297952A (en) 1977-08-17
CH623321A5 (en) 1981-05-29
JPS6017778B2 (ja) 1985-05-07
NL180936B (nl) 1986-12-16
BE848496A (fr) 1977-05-18
DE2651572C2 (de) 1982-05-19
FR2332010B1 (fi) 1979-06-29
SE7612554L (sv) 1977-05-19
DK517076A (da) 1977-05-19
NL180936C (nl) 1987-05-18
ATA854376A (de) 1979-08-15
GB1565080A (en) 1980-04-16
AU510315B2 (en) 1980-06-19
PT65853B (fr) 1978-05-15
CH622770A5 (en) 1981-04-30
IE44265B1 (en) 1981-09-23
DK151330B (da) 1987-11-23
CA1094088A (en) 1981-01-20
FR2332010A1 (fr) 1977-06-17
IL50932A (en) 1984-01-31
NL7612794A (nl) 1977-05-23
DK151330C (da) 1988-04-25

Similar Documents

Publication Publication Date Title
NZ189253A (en) Amine derivatives and pharmaceutical compositions
NZ181726A (en) Pyrrolidine derivatives and pharmaceutical compositions
NZ181444A (en) -phenyl benzylidene derivatives and pharmaceutical compositions
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
GB1518444A (en) N-phenyl-imidazolidine derivatives processes for preparing them and pharmaceutical compositions containing them
NZ182837A (en) Glucosamine derivatives and pharmaceutical compositions
NZ182493A (en) Aminobenzamides and pharmaceutical compositions
NZ182665A (en) Amine derivatives and pharmaceutical compositions
GB1520447A (en) Benzisoquinoline derivatives and pharmaceutical uses thereof
ZA763917B (en) Pharmaceutical compositions and compounds
NZ181959A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ182759A (en) Pyrimidine derivatives and pharmaceutical compositions
PH15711A (en) Acylamino derivatives and pharmaceutical compositions thereof
GB1518041A (en) Oxadiazolinone derivatives and compositions containing them
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
IL48453A0 (en) Novel quinuclidine derivatives and pharmaceutical compositions containing them
PH13912A (en) Substituted benzamide derivatives and pharmaceutical compositions thereof
NZ180535A (en) Erythromicin derivatives and pharmaceutical compositions
NZ181168A (en) 3-sulphamyl benzylamine derivatives and pharmaceutical compositions intermidiates